TY  - JOUR
T1  - Evaluation of Deep Vein Thrombosis Diagnostic and Management Approach
A1  - Awadh M. Al-Antar
A1  - Hassan M. Asiri
A1  - Naif A. Alamri
A1  - Yazed M. Alayesh
A1  - Abdulmalik K. Alsulaimani
A1  - Samar O. Alshammari
A1  - Ali S. Almohammedsaleh
A1  - Zuhair T. AlSulaiman
A1  - Abdullah A. Alatig
A1  - Ibrahim F. Khayyat
A1  - Renad S. AlOtaibi
JF  - Archives of Pharmacy Practice
JO  - Arch Pharm Pract
SN  - 2320-5210
Y1  - 2020
VL  - 11
IS  - 3
SP  - 76
EP  - 78
N2  - Introduction: Deep Vein Thrombosis (DVT) is a common disease and is a subset of venous thromboembolism (VTE). It is a significant preventable cause of mortality and morbidity in the world. Anticoagulant therapeutic approaches such as heparin and also vitamin K antagonists were introduced during the early 20th century. The development of surgical thrombectomy and new vena cava clips treatments were promoted to reduce mortality and avoid unexpected complications. Moreover, new strategies have evolved to diagnose this condition.  Methodology: PubMed published data was used for articles selection and using the following keys in the mesh ((‘’DVT’’[Mesh])), ((‘’VTE ’’[Mesh])) ((‘’Deep Venous Thrombosis ’’[Mesh])), ((‘’Venous’’[Mesh])). Conclusion: DVT is an annoying and prevalent problem for clinicians and it is important to promote diagnosis and treatment. Although the safety profile of DOACs has been quite favorable, dabigatran and rivaroxaban increase the risk of GI bleeding in patients, and further research is necessary.
UR  - https://archivepp.com/article/evaluation-of-deep-vein-thrombosis-diagnostic-and-management-approach
ER  -